NCT01637142 - A Study of LY2140023 in Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Healthy Participants

Interventions

DRUG

LY2140023

Administered orally.

DRUG

14C-LY2140023

Administered IV.

DRUG

14C-LY404039

Administered IV.

Trial Locations (1)

LS2 9LH

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leeds